November 2018 – Thoracic Cancers
November 6
“Managing side effects from lung cancer therapy”
Kavitha Ramchandran, MD
Clinical Associate Professor of Medicine (Oncology)
Stanford University Medical Center
November 13
“Imaging immunotherapy response and novel imaging biomarkers
in thoracic malignancies”
Sharyn Katz, MD
Assistant Professor of Radiology (Division of Thoracic Radiology)
University of Pennsylvania Perelman School of Medicine
November 20
“Early and advanced NSCLC – 2018 updates”
Joel Neal, MD,PhD
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
~and~
“Neuroendocrine lung tumors, thymoma, and mesothelioma – 2018 updates”
Sukhmani Padda, MD, MPH
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
November 27
“Surgical Considerations for Non-Small Cell Lung Cancer”
Doug Liou, MD
Clinical Assistant Professor of Cardiothoracic Surgery
Stanford University School of Medicine
Stanford Cancer Center, 2nd Floor CC-2103, 2104, & 2105, Tuesdays, 8-9am
875 Blake Wilbur Drive, Stanford, CA 94304
Lectures are available for LIVE streaming at https://stanford.zoom.us/j/161118786
PLEASE NOTE: THIS IS A NEW LINK
Select past lectures are available online at http://med.stanford.edu/oncology/oncology-online.html
When offered, CME credit is available for in-person attendance only.
Learners must be in attendance to receive CME credit.
Questions? Contact: Lisa Lowy lowy@stanford.edu
November 2018 – Thoracic Cancers
November 6
“Managing side effects from lung cancer therapy”
Kavitha Ramchandran, MD
Clinical Associate Professor of Medicine (Oncology)
Stanford University Medical Center
November 13
“Imaging immunotherapy response and novel imaging biomarkers
in thoracic malignancies”
Sharyn Katz, MD
Assistant Professor of Radiology (Division of Thoracic Radiology)
University of Pennsylvania Perelman School of Medicine
November 20
“Early and advanced NSCLC – 2018 updates”
Joel Neal, MD,PhD
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
~and~
“Neuroendocrine lung tumors, thymoma, and mesothelioma – 2018 updates”
Sukhmani Padda, MD, MPH
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
November 27
“Surgical Considerations for Non-Small Cell Lung Cancer”
Doug Liou, MD
Clinical Assistant Professor of Cardiothoracic Surgery
Stanford University School of Medicine
Stanford Cancer Center, 2nd Floor CC-2103, 2104, & 2105, Tuesdays, 8-9am
875 Blake Wilbur Drive, Stanford, CA 94304
Lectures are available for LIVE streaming at https://stanford.zoom.us/j/161118786
PLEASE NOTE: THIS IS A NEW LINK
Select past lectures are available online at http://med.stanford.edu/oncology/oncology-online.html
When offered, CME credit is available for in-person attendance only.
Learners must be in attendance to receive CME credit.
Questions? Contact: Lisa Lowy lowy@stanford.edu
Presenter: Beverly Mitchell, MD
Director Emeritus and Senior Adviser, Stanford Cancer Institute
George E. Becker Professor in Medicine, and Professor, by courtesy, of Chemical and Systems Biology, Stanford University
Beverly S. Mitchell, MD, is the Director Emeritus and senior adviser for the Stanford Cancer Institute and is the George E. Becker Professor of Medicine at Stanford University. Before joining the Stanford faculty, Dr. Mitchell lead the Molecular Therapeutics Program at UNC Chapel Hill’s Lineberger Comprehensive Cancer Center, where she also served as Associate Director for Translational Research and Chief of the Division of Hematology/Oncology. She served as Director of the Stanford Cancer Institute for 10 years.
She has authored over 130 peer-reviewed articles. She served as President of the American Society of Hematology (ASH) and was Chair of the Medical and Scientific Affairs Committee and Vice Chair for Medical and Scientific Affairs of the Leukemia and Lymphoma Society of America.
Dr. Mitchell’s current research relates to the development of new therapies for hematologic malignancies. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. Recent studies have focused on the role of nucleolar proteins in cellular stress responses, including that induced by reactive oxygen species. She is also interested in the regulation of ribosomal RNA synthesis in hematopoietic stem and progenitor cells and in the role of dysregulated synthesis in bone marrow failure syndromes. in addition, her laboratory is involved in the translation of these studies into scientifically designed clinical trials.
November 2018 – Thoracic Cancers
November 6
“Managing side effects from lung cancer therapy”
Kavitha Ramchandran, MD
Clinical Associate Professor of Medicine (Oncology)
Stanford University Medical Center
November 13
“Imaging immunotherapy response and novel imaging biomarkers
in thoracic malignancies”
Sharyn Katz, MD
Assistant Professor of Radiology (Division of Thoracic Radiology)
University of Pennsylvania Perelman School of Medicine
November 20
“Early and advanced NSCLC – 2018 updates”
Joel Neal, MD,PhD
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
~and~
“Neuroendocrine lung tumors, thymoma, and mesothelioma – 2018 updates”
Sukhmani Padda, MD, MPH
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
November 27
“Surgical Considerations for Non-Small Cell Lung Cancer”
Doug Liou, MD
Clinical Assistant Professor of Cardiothoracic Surgery
Stanford University School of Medicine
Stanford Cancer Center, 2nd Floor CC-2103, 2104, & 2105, Tuesdays, 8-9am
875 Blake Wilbur Drive, Stanford, CA 94304
Lectures are available for LIVE streaming at https://stanford.zoom.us/j/161118786
PLEASE NOTE: THIS IS A NEW LINK
Select past lectures are available online at http://med.stanford.edu/oncology/oncology-online.html
When offered, CME credit is available for in-person attendance only.
Learners must be in attendance to receive CME credit.
Questions? Contact: Lisa Lowy lowy@stanford.edu
November 2018 – Thoracic Cancers
November 6
“Managing side effects from lung cancer therapy”
Kavitha Ramchandran, MD
Clinical Associate Professor of Medicine (Oncology)
Stanford University Medical Center
November 13
“Imaging immunotherapy response and novel imaging biomarkers
in thoracic malignancies”
Sharyn Katz, MD
Assistant Professor of Radiology (Division of Thoracic Radiology)
University of Pennsylvania Perelman School of Medicine
November 20
“Early and advanced NSCLC – 2018 updates”
Joel Neal, MD,PhD
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
~and~
“Neuroendocrine lung tumors, thymoma, and mesothelioma – 2018 updates”
Sukhmani Padda, MD, MPH
Assistant Professor of Medicine (Oncology)
Stanford University Medical Center
November 27
“Surgical Considerations for Non-Small Cell Lung Cancer”
Doug Liou, MD
Clinical Assistant Professor of Cardiothoracic Surgery
Stanford University School of Medicine
Stanford Cancer Center, 2nd Floor CC-2103, 2104, & 2105, Tuesdays, 8-9am
875 Blake Wilbur Drive, Stanford, CA 94304
Lectures are available for LIVE streaming at https://stanford.zoom.us/j/161118786
PLEASE NOTE: THIS IS A NEW LINK
Select past lectures are available online at http://med.stanford.edu/oncology/oncology-online.html
When offered, CME credit is available for in-person attendance only.
Learners must be in attendance to receive CME credit.
Questions? Contact: Lisa Lowy lowy@stanford.edu
Presenter: Allison Kurian, MD, M.Sc.
Associate Professor of Oncology and Health Research and Policy, Stanford University
Allison W. Kurian, M.D., M.Sc. is an Associate Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, trained as a resident in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University. As Director of the Stanford Women’s Clinical Cancer Genetics Program, Kurian’s clinical practice centers on women at high risk for developing breast and gynecologic cancers.
Kurian’s research focuses on the identification of women with elevated breast and gynecologic cancer risk, and on the development and evaluation of novel techniques for early cancer detection and risk reduction. One current area of investigation is the utility of next-generation sequencing technology for clinical decision-making. Dr. Kurian’s research has been supported by the National Cancer Institute, the Komen Foundation, the American Society of Clinical Oncology, the California Breast Cancer Research Program, the Cancer Research and Prevention Foundation, the Robert Wood Johnson Foundation, and the Breast Cancer Research Foundation.
Presenter: Dr. Umar Mahmood, MD
Vice Chair for Precision Imaging in the Department of Radiology at Massachusetts General Hospital and Professor of Radiology at Harvard Medical School.
Dr. Mahmood’s research has focused on translational applications of molecular imaging to guide precision medicine, with an emphasis on the tumor microenvironment, cancer signaling pathways, changes in cancer metabolism, and the interaction of the immune system with tumors. He is interested in applying image information for disease characterization and optimization of individual treatment response. In addition to his work at MGH, he is Chair of the Board of Scientific Counselors of the NIH Clinical Center. He serves on the Board of Directors and Board of Trustees of RSNA, and serves on the Board of Directors and as Chair of the Scientific Program Committee of SNMMI.
ABSTRACT: Historically, many of the gains in medicine have been achieved by uniformly applying medical insights to large groups of patients. A combination of increasing biological understanding of the heterogeneity of disease processes and the concurrent expansion of available selective therapeutic interventions has provided the opportunity to improve group outcomes by optimizing treatment on an individual basis. In many cases, molecular imaging is ideally suited to serve as a biomarker to guide therapy selection and dosing, and to provide an early assessment of efficacy. This presentation highlights by example several areas in which imaging helps determine target engagement, dynamic cellular response to treatment, and the effectiveness of immune modulation in oncologic treatment.